Author: Piers Townley
-
French neurosurgeons use Virtual Reality to map brain tumour during surgery
On 27 January, a brain tumour patient at Angers hospital wore a Virtual Reality (VR) headset during an awake craniotomy to allow neurosurgeons to ‘map’ his brain tumour as it was being removed.
-
Many NHS MRI machines are out of date according to a recent report
The report discovered that up to 63% of 111 English hospital trusts have at least one scanner that is a decade old, the point where the technology ideally should be scrapped and replaced with upgraded machines.
-
Introducing manifestos for Scotland, Wales and Northern Ireland
This March we’ll be launching manifestos in Scotland, Wales and Northern Ireland ahead of the devolved nations’ elections in May.
-
Public Health England blog outlines the vital importance of collecting cancer patient data
Dr Jem Rashbass, National Director for Disease Registration at Public Health England, has posted a new Public Health England blog about the importance of cancer data.
-
Professor Richard Gilbertson is our new Chair of the Grant Review and Monitoring committee
“My own research lab studies the origins of cancer, particularly childhood brain tumours, and is seeking to develop completely new treatments of these devastating tumours.”
-
Sheffield Children’s Hospital pioneers new ‘sat nav’ of the brain to map tumours
Sheffield Children’s hospital is leading the use of an intraoperative MRI scanner combined with new brain mapping software to identify if they have removed all of the tumour while the patient is still in theatre.
-
Parents of boy who died from a brain tumour create videogame experience
Colorado parents Ryan and Amy Green, have developed That Dragon, Cancer, an interactive videogame experience that documents their 5 year old son, Joel and his struggle and death from a rare form of paediatric brain tumour.
-
American researchers explore cell enzyme as a potential paediatric brain tumour treatment
Researchers from the University of North Carolina Health Care System have been exploring the role of a DNA repair enzyme in cells called Dicer. When they removed this enzyme from preclinical models of medulloblastoma, a brain cancer often found in children, they found increased levels of DNA damage that led to the cell’s death.
-
Research developments in 2016: what the experts think
A major study has asked medical experts across the University of California, San Francisco, what they see as real developments in the coming year.
-
UK-based scientists study trace metal elements to identify brain tumours
Scientists based at Diamond Light Source, the UK’s national synchrotron science facility in Oxfordshire, have used a technique known as x-ray fluorescence to track microscopic trace metals and correctly identify malignant brain tumour cells.
-
Cambridge University scientists develop new blood test for childhood cancers including brain tumours
The new blood test focuses on germ cell cancers that are rare but take root in cells that develop into sperm and eggs and may lead to malignant tumours in childhood.
-
New Zealand tech firm produce virtual reality cancer immunotherapy visualisation
New Zealand-based technology company, Genulin Interactive, have produced a cutting-edge visualisation of cancer immunotherapy.
-
American researchers trial experimental drugs that may halt brain tumour growth
In a report published yesterday in Cancer Cell journal, American researchers are focusing on gene mutations found in a third of brain gliomas.
-
NHS proton beam centres aim to treat a “game-changing” 1,500 patients a year
Two new NHS proton beam centres have commenced construction with planners claiming they could treat 1,500 patients a year.
-
China joins glioblastoma Australian clinical trial project
China joins GBM AGILE, an Australasian adaptive clinical trial project tackling glioblastoma multiforme.